Abstract
Topical treatment of nail psoriasis is complicated by the fact that classical topical drugs formulated for the treatment of skin diseases are not adapted for optimizing drug penetration into and through the nail plate. A new formulation was investigated in two double-blind placebo-controlled studies performed in two centres. The trial formulation contained 8% clobetasol-17-propionate in a colourless nail lacquer vehicle. A therapeutic response was clearly demonstrated and was directly related to the length of treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
